EichorEICHOR
Location: Florida Synced from ClinicalTrials.gov · August 08, 2026

Clinical studies recruiting near Florida

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Phase 4 · Westat · NCT06738407
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Hav
Phase 3 · Pfizer · NCT05020236
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Phase 1 · Erasca, Inc. · NCT06983743
A Study to Investigate the Safety and Efficacy of MEDI0618 Compared to Placebo in Adult Participants With Episodic Migra
Phase 2 · AbbVie · NCT06602479
Shared Decision Making to Improve Goals of Care in the ED
NA · Mayo Clinic · NCT03833622
BioHealx® Anal Fistula Device Post Market Surveillance Study
Phase N/A · Signum Surgical USA Inc. · NCT07021742
A Study to Evaluate Safety, Tolerability and Efficacy of AP306 at Fixed Doses in Dialysis Participants With Hyperphospha
Phase 2 · R1 Therapeutics · NCT06712654
Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753
A Study of Vepugratinib (LY3866288) in Participants With Cancer in the Urinary Tract
Phase 3 · Eli Lilly and Company · NCT07218380
Enhanced Pain Coping in Cancer (EPIC): A Study of Managing Treatment-Related Joint Pain in Breast Cancer Survivors
Phase 2 · Memorial Sloan Kettering Cancer Center · NCT06728579
Investigating the Impact of Electrical Stimulation on Facial Pain, Jaw Movement and Oral Health in People With Motor Neu
NA · Nova Southeastern University · NCT07187388
Symptoms and Functions in Patients With COPD and Chronic Bronchitis Switching From CIG to THS
NA · Philip Morris Products S.A. · NCT07108166
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · Colorado Prevention Center · NCT06024746
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
Phase 3 · Novartis Pharmaceuticals · NCT05755386
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
Phase 2 · Sanofi · NCT06867094
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · Pfizer · NCT07028853
Study of Trastuzumab Deruxtecan Versus Standard of Care Chemotherapy for HER2-Expressing (IHC 3+/2+) Endometrial Cancer
Phase 3 · Daiichi Sankyo · NCT07022483
Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections
Phase N/A · Arkansas Children's Hospital Research Institute · NCT03827694
A Novel Repetitive Synchronized Associative Stimulation Neuromodulation Approach for Spinal Cord Injury Patients
NA · University of Miami · NCT06494059
Pre-myeloid Cancer and Bone Marrow Failure Clinic Study
NA · Mayo Clinic · NCT02958462
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RE
Phase 4 · Alpha Cognition, Inc · NCT07633470
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
NA · Analog Device, Inc. · NCT05650541
The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
Phase 1/Phase 2 · Lin BioScience, Inc · NCT05756322
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valve
NA · Edwards Lifesciences · NCT05172973
A Study to Compare TAK-881 and HYQVIA in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Phase 3 · Takeda · NCT06747351
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or
Phase 3 · CSL Behring · NCT07080905
Real-World Patient Experiences Using Continuous Subcutaneous Apomorphine Infusion (ONAPGOTM) in the United States:
Phase N/A · Supernus Pharmaceuticals, Inc. · NCT07219927
A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559
Incremental Hemodialysis: The TwoPlus Trial
NA · Wake Forest University Health Sciences · NCT05828823
Look up another city
Look up another condition